Mode
Text Size
Log in / Sign up
N/A N=5 Treatment

Functional Connectivity & Stimulation-enhanced Therapy Post Stroke

Stroke

Enrolled (actual)
5
Serious AEs
0.0%
Results posted
Mar 2019
Primary outcome: Primary: Mean Change in Hand Motor Function — 0.83 blocks

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
task-practice therapy (Behavioral); Vibration (Other)
Age
Adult, Older Adult · 18+ yrs
Sex
All
Sponsor
Medical University of South Carolina
Primary completion
Sep 2018

Outcome Measures

OutcomeResultp-value
PRIMARY
Mean Change in Hand Motor Function
-14.24
PRIMARY
Mean Change in Hand Motor Function
-14.24
SECONDARY
Mean Change in Hand Motor Function
-14.24
SECONDARY
Mean Change in Hand Motor Function
-14.24

Summary

After stroke, it is common for individuals to experience hand impairment. This deficit can severely restrict functional ability and independence. Recovery of hand function following stroke is highly variable. In this study, the investigators will use brain imaging to predict individual response to treatment. Survivors of stroke will receive upper extremity therapy while they concurrently receive imperceptible vibration to the wrist aimed to enhance therapy outcomes.

Eligibility Criteria

Inclusion Criteria

  • Age = 18 or older
  • At least 6 months post-stroke
  • Moderate upper limb impairment with the ability to participate in hand task practices
  • Fingertip touch sensory deficits (e.g., Monofilament>2.83, 2-point discrimination>5mm, sense of numbness, tingling)

Exclusion Criteria

  • Complete upper limb deafferentation
  • Rigidity (Modified Ashworth Scale=5)
  • Botulinum toxin injection within 3 months prior to enrollment or during enrollment
  • Brainstem stroke
  • Comorbidity (peripheral neuropathy, orthopaedic conditions in the hand that limit ranges of motion, premorbid neurologic conditions, compromised skin integrity of the hand/wrist due to long-term use of blood thinners)
  • Concurrent upper extremity rehabilitation therapy
  • Language barrier or cognitive impairment that precludes following instructions or providing consent
  • MRI incompatible.
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT03473808). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search